|
EXPERTS
Biomaterials: from old choices to new
designs
Scientific
progress, especially the recent strides made in
nanotechnology and stem cell research, have offered us a
glimpse into the future of regenerative medicine and
tissue engineering.The success of regenerative medicine
will ultimately stem from the accuracy achieved in the
de novo design of the specific biomaterials
used.
Read more Dr. Josep A.
Planell
Director of the IBEC |
POINTS OF
VIEW
Antoni Giralt: “The Alternative Stock
Market can become a key toll for funding biotechnology
companies”
In 2009 the
Alternative Stock Market (MAB) was started up for
growing companies. Presided over by Antoni Giralt
–deputy CEO of the Barcelona Stock Exchange and a member
of the Coordination Committee for the Spanish Stock
Markets and Exchanges (BME) –, the MAB currently
includes eight companies from a number of
sectors.
Read more |
NEWS
Biocat, CataloniaBio and Barcelona Chamber
of Commerce align strategies to drive the Catalan
biotech sector
Read more
New call for proposals for the
International PhD Fellowship Program at the Center for
Genomic Regulation in Barcelona
Read more
Anaxomics Biotech launches the global
collaborative drug-reprofiling initiative
Read
more |
